• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
The Johns Hopkins Textbook of Dyslipidemia

The Johns Hopkins Textbook of Dyslipidemia

9780781782654
535,50 zł
481,95 zł Zniżka 53,55 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 481,95 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis

The first comprehensive text on dyslipidemia from a major academic institution, this book covers all aspects of dyslipidemia as it relates to human disease, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and pancreatitis. The material is presented in a clinician-friendly format and includes references for additional reading.

Reflecting current guidelines from the National Cholesterol Education Program, the book explains why, when, and how to treat dyslipidemia. Coverage includes dietary treatment, drug treatment, and recommendations for special populations such as patients with coronary heart disease, patients at high risk for coronary heart disease, patients with diabetes, women, older adults, young adults, and racial and ethnic groups.

Szczegóły produktu
LWW
43599
9780781782654
9780781782654

Opis

Rok wydania
2009
Numer wydania
1
Oprawa
twarda
Liczba stron
320
Wymiary (mm)
213 x 276
Waga (g)
975
  • SECTION I FUNDAMENTAL ASPECTS OF DYSLIPIDEMIA AND ATHEROSCLEROSIS

    Chapter 1:: Lipid, Apolipoprotein, and Lipoprotein Metabolism:: Implications for the Diagnosis of Dyslipidemia

    Chapter 2:: Measurement of Lipids, Lipoproteins, and Apolipoproteins

    Chapter 3:: Pathogenesis of Atherosclerosis and the Unstable Plaque

    Chapter 4:: Pathophysiology and Vascular Biology of Atherosclerosis

    Chapter 5:: Clinical Trial Evidence for Treatment of Dyslipidemia in the Prevention of Cardiovascular Disease

    Chapter 6:: Use of Noninvasive Methods to Diagnose Cardiovascular Disease in Dyslipidemic Patients

    SECTION II METABOLIC DISORDERS OF DYSLIPIDEMIA

    Chapter 7:: Disorders of Hypertriglyceridemia

    Chapter 8:: Disorders of LDL Metabolism

    Chapter 9:: Disorders of HDL Metabolism

    SECTION III DYSLIPIDEMIA IN SPECIAL GROUPS

    Chapter 10:: Pathophysiology and Treatment of Dyslipidemia in Diabetes

    Chapter 11:: Dyslipidemia in Renal Disease

    Chapter 12:: Dyslipidemia in Children and Adolescents

    Chapter 13:: Dyslipidemia and Atherosclerosis in Women

    Chapter 14:: Dyslipidemia in the Elderly:: Special Insights to Inform the Management Strategy

    SECTION IV NONTRADITIONAL RISK FACTORS AND CARDIOVASCULAR DISEASE

    Chapter 15:: Clinical Utility of Inflammatory Markers

    Chapter 16:: ApoB and the Atherogenic ApoB Dyslipoproteinemias

    Chapter 17:: Other Nontraditional Risk Factors for Cardiovascular Disease

    Chapter 18:: Lipoprotein (A):: A Pleotrophic Risk Factor for Cardiovascular Disease

    SECTION V DIETARY AND PHARMACOLOGIC TREATMENT OF DYSLIPIDEMIA AND CARDIOVASCULAR DISEASE

    Chapter 19:: Dietary Treatment of Dyslipidemia

    Chapter 20:: Trans Fatty Acids, Dyslipidemia, and Cardiovascular Disease

    Chapter 21:: Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease

    Chapter 22:: Effect of Exercise on Dyslipidemia

    Chapter 23:: Pharmacologic Treatment of Dyslipidemia and Cardiovascular Disease

    Chapter 24:: Therapeutic Options for Modifying Obesity and Cardiometabolic Risk Factors

    Index

Komentarze (0)